News
Company ImmuPharma PLC
TIDM IMM
Headline Annual Report and Accounts
Released 07:00 30-Jun-2009
Number 7193U07
FOR IMMEDIATE RELEASE
London, 30 June 2009
Annual Report and Accounts
In accordance with Rule 20 of the AIM Rules, ImmuPharma PLC (AIM:IMM), the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2008, has been posted to shareholders.
The annual report is available, in electronic form, for download on the Company's website www.immupharma.com.
The Company's Annual General Meeting will be held on 24 July 2009 at 11am at 50 Broadway, London, SW1H 0BL.
For further information please contact:
ImmuPharma PLC +44 20 7152 4080
Dimitri Dimitriou, Chief Executive Officer
Richard Warr, Chairman
Buchanan Communications +44 20 7466 5000
Lisa Baderoon
Rebecca Skye Dietrich
Panmure Gordon & Co 44 151 243 0963
Andrew Burnett
© London Stock Exchange plc. All rights reserved